Company Overview
Snapshot
Founded in November 2018 by Tsvi Dahan and Meir Dahan, Hila Pharma operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on developing products for molecular imaging.
Business overview
Hila Pharma specializes in developing molecular imaging products designed to enable precise diagnoses and enhance therapy planning. The company's core offerings are in nuclear medicine, providing a wide array of products for both diagnostic and therapeutic applications. These include SPECT and PET diagnostic products, MRI contrast agents, and various nuclear therapeutic materials such as LU-177. Hila Pharma serves markets globally and in Israel, operating across sectors such as Health Tech & Life Sciences, Medical Devices, and Pharma & Medical Biotechnology, with a focus on healthcare providers, government, and public transportation.
Strategic signal
In September 2020, Hila Pharma's ProtectAir product was reported to kill over 99% of airborne viruses. This development signals the company's potential to address critical public health needs with innovative solutions, offering a strong validation of its research and development capabilities in combating infectious agents.
Log in to access full profile ›Company Intelligence Q&A
- When was Hila Pharma founded?
- Hila Pharma was founded in November 2018 by Tsvi Dahan and Meir Dahan.
- What is Hila Pharma's primary focus?
- Hila Pharma primarily focuses on developing products for molecular imaging to enable precise diagnoses and improved therapy planning, with a strong emphasis on nuclear medicine.
- What types of products does Hila Pharma offer?
- Hila Pharma offers a broad range of products for nuclear medicine, including SPECT and PET diagnostic products, MRI contrast agents, and nuclear therapeutic materials like LU-177.
- What was a significant product development for Hila Pharma?
- In September 2020, Hila Pharma's ProtectAir product was reported to kill over 99% of airborne viruses, showcasing its innovation in combating infectious agents.
- Which markets does Hila Pharma serve?
- Hila Pharma serves global and Israeli markets, targeting healthcare providers, government, and public transportation sectors with its medical imaging and therapeutic solutions.